Source: CIDRAP
A study published in PLOS One analyzed data from Germany’s Veterinary practices, revealing that approximately 12% of Escherichia coli isolates from dogs and cats are resistant to third-generation cephalosporins, specifically cefovecin, the only one approved for veterinary use. Researchers examined 25,491 E. coli strains from 175,171 samples across 3,491 practices (33% of all practices nationwide) between 2019 and 2021.
Resistance levels varied regionally, with some areas showing rates up to 15%. In addition, cefovecin-resistant E. coli displayed high resistance to other antibiotics, such as trimethoprim-sulfamethoxazole (30%) and chloramphenicol (28%). Given the close contact between pets and owners, the study emphasizes the significance of monitoring antimicrobial resistance (AMR) in companion animals to safeguard human health. The findings underscore the need for integrated AMR surveillance to better understand resistance patterns and promote optimal antibiotic use for both human and animal health.
Read the full story HERE: https://www.cidrap.umn.edu/antimicrobial-stewardship/german-study-finds-concerning-rate-resistant-e-coli-cats-and-dogs